Business classification
VCID: 274503
Profile
Corporate information
Official name
Eli Lilly & Co
Registration country
Official name
Eli Lilly & Co
Registration country
Investment activity status
Active investor
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Round participant. Active |
|
|
Zephyr AI Inc Precision medicine startup. |
United States | 13 Mar 2024 | Series A Initial investment. Round participant. Active |
|
|
Mission Bay Capital III |
16 Sep 2019 | Fund Closing Active |
||
|
Novartis Animal Health |
22 Apr 2014 | Acquisition USD 5,400,000,000 (USD 5,400,000,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
Imclone Systems |
24 Nov 2008 | Acquisition USD 7,133,620,000 (USD 7,133,620,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
INext Fund |
United States | Fund Closing Active |
